Data Analytics Platform Will Optimize Clinical Operations By End Of 2024

Published
28 Jan 25
Updated
19 May 25
AnalystConsensusTarget's Fair Value
R16.42
15.5% undervalued intrinsic discount
19 May
R13.87
Loading
1Y
10.1%
7D
2.2%

Author's Valuation

R16.4

15.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 3.41%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.25%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 3.01%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.